Uromodulin storage diseases: Clinical aspects and mechanisms

The recent discovery of mutations in the uromodulin gene ( UMOD) in patients with medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and glomerulocystic kidney disease (GCKD) provides the opportunity for a revision of pathogenic aspects and puts forth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of kidney diseases 2004-12, Vol.44 (6), p.987-999
Hauptverfasser: Scolari, Francesco, Caridi, Gianluca, Rampoldi, Luca, Tardanico, Regina, Izzi, Claudia, Pirulli, Doroti, Amoroso, Antonio, Casari, Giorgio, Ghiggeri, Gian Marco
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 999
container_issue 6
container_start_page 987
container_title American journal of kidney diseases
container_volume 44
creator Scolari, Francesco
Caridi, Gianluca
Rampoldi, Luca
Tardanico, Regina
Izzi, Claudia
Pirulli, Doroti
Amoroso, Antonio
Casari, Giorgio
Ghiggeri, Gian Marco
description The recent discovery of mutations in the uromodulin gene ( UMOD) in patients with medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and glomerulocystic kidney disease (GCKD) provides the opportunity for a revision of pathogenic aspects and puts forth the basis for a renewed classification. This review focuses on clinical, pathological, and cell biology advances in UMOD-related pathological states, including a review of the associated clinical conditions described to date in the literature. Overall, 31 UMOD mutations associated with MCKD2 and FJHN (205 patients) and 1 mutation associated with GCKD (3 patients) have been described, with a cluster at exons 4 and 5. Most are missense mutations causing a cysteine change in uromodulin sequence. No differences in clinical symptoms between carriers of cysteine versus polar residue changes have been observed; clinical phenotypes invariably are linked to classic MCKD2/FJHN. A common motif among all reports is that many overlapping symptoms between MCKD2 and FJHN are present, and a separation between these 2 entities seems unwarranted or redundant. Cell experiments with mutant variants indicated a delay in intracellular maturation and export dynamics, with consequent uromodulin storage within the endoplasmic reticulum (ER). Patchy uromodulin deposits in tubule cells were found by means of immunohistochemistry, and electron microscopy showed dense fibrillar material in the ER. Mass spectrometry showed only unmodified uromodulin in urine of patients with UMOD mutations. Lack of uromodulin function(s) is associated with impairments in tubular function, particularly the urine-concentrating process, determining water depletion and hyperuricemia. Intracellular uromodulin trapping within the ER probably has a major role in determining tubulointerstitial fibrosis and renal failure. We propose the definition of uromodulin storage diseases for conditions with proven UMOD mutations.
doi_str_mv 10.1053/j.ajkd.2004.08.021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67087359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0272638604012557</els_id><sourcerecordid>67087359</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-8b47221b4e8c84f731d861a376a03449c1d14b1a902328f34180c11d602ac9a33</originalsourceid><addsrcrecordid>eNp90E1rGzEQgGFRGhon7R_ooeylve1mRtJqtSWXYNq0EMilOYuxpG3l7oersQP995WxIbeeBMM7g3iEeI_QILTqZtvQ9ndoJIBuwDYg8ZVYYStVbayyr8UKZCdro6y5FFfMWwDolTFvxCW2bWtb7Ffi9ikv0xIOY5or3i-ZfsYqJI7EkT9X6zJOnsaKeBf9niuaQzVF_4vmxBO_FRcDjRzfnd9r8fT1y4_1t_rh8f77-u6h9rqX-9pudCclbnS03uqhUxisQVKdIVBa9x4D6g1SD1JJOyiNFjxiMCDJ96TUtfh0urvLy59D5L2bEvs4jjTH5cDOdGA71fYllKfQ54U5x8Htcpoo_3UI7mjmtu5o5o5mDqwrZmXpw_n6YTPF8LJyRirBx3NAXDCGTLNP_NIZha0yunS3py4Wi-cUs2Of4uxjSLnoubCk__3jH2M_iHU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67087359</pqid></control><display><type>article</type><title>Uromodulin storage diseases: Clinical aspects and mechanisms</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Scolari, Francesco ; Caridi, Gianluca ; Rampoldi, Luca ; Tardanico, Regina ; Izzi, Claudia ; Pirulli, Doroti ; Amoroso, Antonio ; Casari, Giorgio ; Ghiggeri, Gian Marco</creator><creatorcontrib>Scolari, Francesco ; Caridi, Gianluca ; Rampoldi, Luca ; Tardanico, Regina ; Izzi, Claudia ; Pirulli, Doroti ; Amoroso, Antonio ; Casari, Giorgio ; Ghiggeri, Gian Marco</creatorcontrib><description>The recent discovery of mutations in the uromodulin gene ( UMOD) in patients with medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and glomerulocystic kidney disease (GCKD) provides the opportunity for a revision of pathogenic aspects and puts forth the basis for a renewed classification. This review focuses on clinical, pathological, and cell biology advances in UMOD-related pathological states, including a review of the associated clinical conditions described to date in the literature. Overall, 31 UMOD mutations associated with MCKD2 and FJHN (205 patients) and 1 mutation associated with GCKD (3 patients) have been described, with a cluster at exons 4 and 5. Most are missense mutations causing a cysteine change in uromodulin sequence. No differences in clinical symptoms between carriers of cysteine versus polar residue changes have been observed; clinical phenotypes invariably are linked to classic MCKD2/FJHN. A common motif among all reports is that many overlapping symptoms between MCKD2 and FJHN are present, and a separation between these 2 entities seems unwarranted or redundant. Cell experiments with mutant variants indicated a delay in intracellular maturation and export dynamics, with consequent uromodulin storage within the endoplasmic reticulum (ER). Patchy uromodulin deposits in tubule cells were found by means of immunohistochemistry, and electron microscopy showed dense fibrillar material in the ER. Mass spectrometry showed only unmodified uromodulin in urine of patients with UMOD mutations. Lack of uromodulin function(s) is associated with impairments in tubular function, particularly the urine-concentrating process, determining water depletion and hyperuricemia. Intracellular uromodulin trapping within the ER probably has a major role in determining tubulointerstitial fibrosis and renal failure. We propose the definition of uromodulin storage diseases for conditions with proven UMOD mutations.</description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2004.08.021</identifier><identifier>PMID: 15558519</identifier><language>eng</language><publisher>Orlando, FL: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; familial juvenile hyperuricemic nephropathy (FJHN) ; glomerulocystic kidney disease (GCKD) ; Humans ; Kidney Diseases - pathology ; Medical sciences ; medullary cystic kidney disease (MCKD) ; Metabolism, Inborn Errors - metabolism ; Metabolism, Inborn Errors - pathology ; Mucoproteins - metabolism ; Nephrology. Urinary tract diseases ; Tamm-Horsfall protein ; Uromodulin</subject><ispartof>American journal of kidney diseases, 2004-12, Vol.44 (6), p.987-999</ispartof><rights>2004 National Kidney Foundation, Inc.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-8b47221b4e8c84f731d861a376a03449c1d14b1a902328f34180c11d602ac9a33</citedby><cites>FETCH-LOGICAL-c492t-8b47221b4e8c84f731d861a376a03449c1d14b1a902328f34180c11d602ac9a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.ajkd.2004.08.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27925,27926,45996</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16315364$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15558519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scolari, Francesco</creatorcontrib><creatorcontrib>Caridi, Gianluca</creatorcontrib><creatorcontrib>Rampoldi, Luca</creatorcontrib><creatorcontrib>Tardanico, Regina</creatorcontrib><creatorcontrib>Izzi, Claudia</creatorcontrib><creatorcontrib>Pirulli, Doroti</creatorcontrib><creatorcontrib>Amoroso, Antonio</creatorcontrib><creatorcontrib>Casari, Giorgio</creatorcontrib><creatorcontrib>Ghiggeri, Gian Marco</creatorcontrib><title>Uromodulin storage diseases: Clinical aspects and mechanisms</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>The recent discovery of mutations in the uromodulin gene ( UMOD) in patients with medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and glomerulocystic kidney disease (GCKD) provides the opportunity for a revision of pathogenic aspects and puts forth the basis for a renewed classification. This review focuses on clinical, pathological, and cell biology advances in UMOD-related pathological states, including a review of the associated clinical conditions described to date in the literature. Overall, 31 UMOD mutations associated with MCKD2 and FJHN (205 patients) and 1 mutation associated with GCKD (3 patients) have been described, with a cluster at exons 4 and 5. Most are missense mutations causing a cysteine change in uromodulin sequence. No differences in clinical symptoms between carriers of cysteine versus polar residue changes have been observed; clinical phenotypes invariably are linked to classic MCKD2/FJHN. A common motif among all reports is that many overlapping symptoms between MCKD2 and FJHN are present, and a separation between these 2 entities seems unwarranted or redundant. Cell experiments with mutant variants indicated a delay in intracellular maturation and export dynamics, with consequent uromodulin storage within the endoplasmic reticulum (ER). Patchy uromodulin deposits in tubule cells were found by means of immunohistochemistry, and electron microscopy showed dense fibrillar material in the ER. Mass spectrometry showed only unmodified uromodulin in urine of patients with UMOD mutations. Lack of uromodulin function(s) is associated with impairments in tubular function, particularly the urine-concentrating process, determining water depletion and hyperuricemia. Intracellular uromodulin trapping within the ER probably has a major role in determining tubulointerstitial fibrosis and renal failure. We propose the definition of uromodulin storage diseases for conditions with proven UMOD mutations.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>familial juvenile hyperuricemic nephropathy (FJHN)</subject><subject>glomerulocystic kidney disease (GCKD)</subject><subject>Humans</subject><subject>Kidney Diseases - pathology</subject><subject>Medical sciences</subject><subject>medullary cystic kidney disease (MCKD)</subject><subject>Metabolism, Inborn Errors - metabolism</subject><subject>Metabolism, Inborn Errors - pathology</subject><subject>Mucoproteins - metabolism</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Tamm-Horsfall protein</subject><subject>Uromodulin</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90E1rGzEQgGFRGhon7R_ooeylve1mRtJqtSWXYNq0EMilOYuxpG3l7oersQP995WxIbeeBMM7g3iEeI_QILTqZtvQ9ndoJIBuwDYg8ZVYYStVbayyr8UKZCdro6y5FFfMWwDolTFvxCW2bWtb7Ffi9ikv0xIOY5or3i-ZfsYqJI7EkT9X6zJOnsaKeBf9niuaQzVF_4vmxBO_FRcDjRzfnd9r8fT1y4_1t_rh8f77-u6h9rqX-9pudCclbnS03uqhUxisQVKdIVBa9x4D6g1SD1JJOyiNFjxiMCDJ96TUtfh0urvLy59D5L2bEvs4jjTH5cDOdGA71fYllKfQ54U5x8Htcpoo_3UI7mjmtu5o5o5mDqwrZmXpw_n6YTPF8LJyRirBx3NAXDCGTLNP_NIZha0yunS3py4Wi-cUs2Of4uxjSLnoubCk__3jH2M_iHU</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Scolari, Francesco</creator><creator>Caridi, Gianluca</creator><creator>Rampoldi, Luca</creator><creator>Tardanico, Regina</creator><creator>Izzi, Claudia</creator><creator>Pirulli, Doroti</creator><creator>Amoroso, Antonio</creator><creator>Casari, Giorgio</creator><creator>Ghiggeri, Gian Marco</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Uromodulin storage diseases: Clinical aspects and mechanisms</title><author>Scolari, Francesco ; Caridi, Gianluca ; Rampoldi, Luca ; Tardanico, Regina ; Izzi, Claudia ; Pirulli, Doroti ; Amoroso, Antonio ; Casari, Giorgio ; Ghiggeri, Gian Marco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-8b47221b4e8c84f731d861a376a03449c1d14b1a902328f34180c11d602ac9a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>familial juvenile hyperuricemic nephropathy (FJHN)</topic><topic>glomerulocystic kidney disease (GCKD)</topic><topic>Humans</topic><topic>Kidney Diseases - pathology</topic><topic>Medical sciences</topic><topic>medullary cystic kidney disease (MCKD)</topic><topic>Metabolism, Inborn Errors - metabolism</topic><topic>Metabolism, Inborn Errors - pathology</topic><topic>Mucoproteins - metabolism</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Tamm-Horsfall protein</topic><topic>Uromodulin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scolari, Francesco</creatorcontrib><creatorcontrib>Caridi, Gianluca</creatorcontrib><creatorcontrib>Rampoldi, Luca</creatorcontrib><creatorcontrib>Tardanico, Regina</creatorcontrib><creatorcontrib>Izzi, Claudia</creatorcontrib><creatorcontrib>Pirulli, Doroti</creatorcontrib><creatorcontrib>Amoroso, Antonio</creatorcontrib><creatorcontrib>Casari, Giorgio</creatorcontrib><creatorcontrib>Ghiggeri, Gian Marco</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scolari, Francesco</au><au>Caridi, Gianluca</au><au>Rampoldi, Luca</au><au>Tardanico, Regina</au><au>Izzi, Claudia</au><au>Pirulli, Doroti</au><au>Amoroso, Antonio</au><au>Casari, Giorgio</au><au>Ghiggeri, Gian Marco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uromodulin storage diseases: Clinical aspects and mechanisms</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>44</volume><issue>6</issue><spage>987</spage><epage>999</epage><pages>987-999</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract>The recent discovery of mutations in the uromodulin gene ( UMOD) in patients with medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and glomerulocystic kidney disease (GCKD) provides the opportunity for a revision of pathogenic aspects and puts forth the basis for a renewed classification. This review focuses on clinical, pathological, and cell biology advances in UMOD-related pathological states, including a review of the associated clinical conditions described to date in the literature. Overall, 31 UMOD mutations associated with MCKD2 and FJHN (205 patients) and 1 mutation associated with GCKD (3 patients) have been described, with a cluster at exons 4 and 5. Most are missense mutations causing a cysteine change in uromodulin sequence. No differences in clinical symptoms between carriers of cysteine versus polar residue changes have been observed; clinical phenotypes invariably are linked to classic MCKD2/FJHN. A common motif among all reports is that many overlapping symptoms between MCKD2 and FJHN are present, and a separation between these 2 entities seems unwarranted or redundant. Cell experiments with mutant variants indicated a delay in intracellular maturation and export dynamics, with consequent uromodulin storage within the endoplasmic reticulum (ER). Patchy uromodulin deposits in tubule cells were found by means of immunohistochemistry, and electron microscopy showed dense fibrillar material in the ER. Mass spectrometry showed only unmodified uromodulin in urine of patients with UMOD mutations. Lack of uromodulin function(s) is associated with impairments in tubular function, particularly the urine-concentrating process, determining water depletion and hyperuricemia. Intracellular uromodulin trapping within the ER probably has a major role in determining tubulointerstitial fibrosis and renal failure. We propose the definition of uromodulin storage diseases for conditions with proven UMOD mutations.</abstract><cop>Orlando, FL</cop><pub>Elsevier Inc</pub><pmid>15558519</pmid><doi>10.1053/j.ajkd.2004.08.021</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0272-6386
ispartof American journal of kidney diseases, 2004-12, Vol.44 (6), p.987-999
issn 0272-6386
1523-6838
language eng
recordid cdi_proquest_miscellaneous_67087359
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Biological and medical sciences
familial juvenile hyperuricemic nephropathy (FJHN)
glomerulocystic kidney disease (GCKD)
Humans
Kidney Diseases - pathology
Medical sciences
medullary cystic kidney disease (MCKD)
Metabolism, Inborn Errors - metabolism
Metabolism, Inborn Errors - pathology
Mucoproteins - metabolism
Nephrology. Urinary tract diseases
Tamm-Horsfall protein
Uromodulin
title Uromodulin storage diseases: Clinical aspects and mechanisms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T15%3A00%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uromodulin%20storage%20diseases:%20Clinical%20aspects%20and%20mechanisms&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Scolari,%20Francesco&rft.date=2004-12-01&rft.volume=44&rft.issue=6&rft.spage=987&rft.epage=999&rft.pages=987-999&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2004.08.021&rft_dat=%3Cproquest_cross%3E67087359%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67087359&rft_id=info:pmid/15558519&rft_els_id=S0272638604012557&rfr_iscdi=true